Most cells in the human body are specialized. Red blood cells transport oxygen, neurons transmit electrical signals, and muscle cells contract.

Stem cells are different.

Stem cells are relatively unspecialized cells with two particularly important abilities:

• they can self-renew, producing more stem cells
• they can differentiate, producing specialized cell types

These properties make stem cells extremely important during development and tissue maintenance—and potentially useful in medicine.

Regenerative medicine aims to repair, replace, or regenerate cells, tissues, or organs that have been damaged by injury, disease, or aging.

---

What Is a Stem Cell?

A stem cell is a cell that can:

1. Self-renew

and

2. Differentiate into one or more specialized cell types

These two properties distinguish stem cells from many mature specialized cells.

A simplified pathway is:

stem cell

↙ ↓ ↘

more stem cells — specialized cell A — specialized cell B

Self-renewal maintains the stem-cell population.

Differentiation produces cells needed for development, maintenance, or repair.

---

Self-Renewal

Self-renewal means that a stem cell can divide while maintaining the stem-cell population.

For example:

stem cell → cell division → stem cells remain available

This is important because if every stem cell immediately differentiated, the supply of stem cells would eventually disappear.

Some stem cells can therefore maintain populations for very long periods.

---

Differentiation

Differentiation is the process through which an unspecialized cell develops characteristics of a specialized cell.

Examples of specialized cells include:

• neurons
• muscle cells
• red blood cells
• white blood cells
• skin cells
• intestinal cells

During differentiation, cells can change their:

• shape
• internal structures
• proteins
• metabolism
• functions

Yet most cells still contain essentially the same genome.

So how can genetically similar cells become so different?

---

Gene Expression and Differentiation

The answer lies largely in gene expression.

Cells do not use all their genes equally.

Different genes can be:

more active

or

less active

in different cell types.

For example:

Muscle Cell

Expresses many genes associated with contraction.

Neuron

Expresses genes involved in electrical signalling and communication.

Red Blood Cell Precursor

Expresses genes needed for producing large amounts of hemoglobin.

Therefore:

same basic genome + different patterns of gene expression → different cell types

---

What Controls Differentiation?

Differentiation is controlled by complex interactions involving:

• genes
• regulatory proteins
• chemical signals
• neighbouring cells
• hormones and growth factors
• the extracellular environment

Cells receive signals that influence which genes become more or less active.

These changes alter which proteins are produced.

The proteins then affect the structure and function of the cell.

A simplified sequence is:

signal received

↓

gene expression changes

↓

different proteins produced

↓

cell structure changes

↓

cell becomes specialized

---

Potency

Not all stem cells can produce the same range of cell types.

Their developmental potential is described using the idea of potency.

Major categories include:

• totipotent
• pluripotent
• multipotent
• unipotent

These terms describe progressively narrower developmental potential.

---

Totipotent Stem Cells

Totipotent cells have the greatest developmental potential.

In humans, the fertilized egg and cells from the earliest stages of development can give rise to the cell types needed to form the embryo as well as supporting extraembryonic tissues.

The fertilized egg is called a zygote.

zygote → early embryonic cells → many developmental pathways

Totipotency exists only during very early development.

---

Pluripotent Stem Cells

Pluripotent stem cells can produce cells representing essentially all major cell types of the body.

They cannot, by themselves, form all of the extraembryonic structures required to develop into a complete organism.

Embryonic stem cells are pluripotent.

Pluripotency is scientifically important because one stem-cell population has the potential to produce many different specialized cell types.

---

Multipotent Stem Cells

Multipotent stem cells can differentiate into several related cell types, usually within a particular tissue or developmental lineage.

An important example is the hematopoietic stem cell.

These stem cells are found mainly in bone marrow and can produce the different types of blood cells.

hematopoietic stem cell

↓

blood-cell lineages

↓

• red blood cells
• several white blood cell types
• platelet-producing cells

---

Unipotent Stem Cells

Some stem or progenitor cells have a much narrower developmental potential.

A unipotent stem cell produces essentially one specialized cell type while retaining some ability to self-renew.

These cells can still be important for maintaining tissues.

The general pattern is:

greater potency → more possible cell types

lower potency → fewer possible cell types

---

Stem Cells in the Adult Body

Stem cells are not found only in embryos.

Many adult tissues contain populations of adult stem cells, sometimes called somatic stem cells.

Their role is usually to:

• maintain tissues
• replace lost cells
• repair damage

Examples are associated with:

• bone marrow
• skin
• intestine
• skeletal muscle
• parts of the nervous system

---

Bone Marrow Stem Cells

Bone marrow contains hematopoietic stem cells, which continuously produce new blood cells.

This is essential because many blood cells have limited lifespans.

The body must constantly replace them.

For example, enormous numbers of red blood cells are produced every day.

Without stem cells:

old cells lost → no replacement → tissue function fails

Stem cells therefore play an essential role in normal body maintenance.

---

Stem Cells in the Intestine

The lining of the intestine experiences considerable wear.

Cells are continually lost and replaced.

Stem cells located in intestinal structures called crypts divide and produce cells that differentiate into the specialized cells of the intestinal lining.

This creates a continuous cycle:

stem cell division → differentiation → mature intestinal cells → cells lost → replacement

---

Stem Cells in Skin

Skin also requires continuous renewal.

Stem-cell populations help replace cells lost through:

• normal shedding
• minor injuries
• tissue wear

Following injury, cell division and differentiation can increase to help repair damaged tissue.

This demonstrates that regeneration is already a natural process occurring throughout the body.

Regenerative medicine attempts to understand and sometimes enhance or reproduce these processes.

---

Embryonic Stem Cells

Embryonic stem cells (ESCs) are pluripotent stem cells derived from early-stage embryos.

Their major scientific advantage is their developmental potential.

Under suitable laboratory conditions, researchers can direct them toward cell types such as:

• neurons
• heart muscle cells
• pancreatic cell types
• retinal cells

This makes embryonic stem cells valuable for studying:

• development
• genetic disease
• cell differentiation
• potential regenerative therapies

However, their origin creates significant ethical debate.

---

Adult Stem Cells

Adult stem cells are found in developed tissues.

Examples include:

• hematopoietic stem cells
• intestinal stem cells
• skin stem cells

Compared with pluripotent stem cells, adult stem cells usually have a more limited range of differentiation.

For example:

hematopoietic stem cell → blood cells

rather than:

hematopoietic stem cell → neuron, liver cell, heart cell, etc.

Their more restricted potential can limit some applications, but adult stem cells are already extremely important in medicine.

---

Induced Pluripotent Stem Cells

A major breakthrough occurred when scientists discovered that mature specialized cells could be reprogrammed into a pluripotent-like state.

These are called:

induced pluripotent stem cells (iPSCs).

A simplified pathway is:

specialized adult cell

↓

reprogramming factors introduced

↓

gene-expression pattern changes

↓

cell returns to pluripotent-like state

↓

iPSC

↓

directed differentiation

↓

new specialized cell types

This discovery changed stem-cell research dramatically.

---

Why Are iPSCs Important?

iPSCs provide several potential advantages.

Scientists can take cells from a person and create pluripotent stem-cell lines.

These cells can then be differentiated into particular cell types.

For example:

patient skin cell

↓

iPSC

↓

heart muscle cell

Researchers could then study how the patient's genetic background affects heart-cell function.

This creates powerful possibilities for:

• disease modelling
• drug testing
• personalized medicine
• regenerative medicine

---

Stem Cells in Medicine

Stem cells have both established and experimental medical applications.

It is important to distinguish between the two.

Some stem-cell treatments have been used successfully for decades.

Others remain under investigation.

A claim that something is a "stem-cell treatment" does not automatically mean that it has been shown to be safe and effective.

---

Bone Marrow and Blood Stem-Cell Transplants

One of the best-established stem-cell treatments is hematopoietic stem-cell transplantation.

It can be used for some diseases affecting the blood or immune system.

Examples include certain:

• leukemias
• lymphomas
• blood disorders
• immune disorders

A simplified process is:

healthy blood-forming stem cells obtained

↓

patient receives preparation treatment

↓

stem cells introduced into bloodstream

↓

cells reach bone marrow

↓

new blood cells produced

---

Why Can Stem-Cell Transplants Treat Leukemia?

Leukemia involves abnormal blood-forming cells.

Some treatments destroy abnormal cells but can also damage normal blood-forming stem cells.

A stem-cell transplant can provide healthy cells capable of rebuilding the blood-forming system.

The transplanted stem cells can:

self-renew

and

differentiate into blood-cell types

This demonstrates how the two defining properties of stem cells can have direct medical value.

---

Regenerative Medicine

Regenerative medicine aims to restore the structure or function of damaged tissues.

The goal may be to:

• replace damaged cells
• stimulate the body's own repair processes
• grow replacement tissues
• combine cells with biomaterials
• genetically correct cells before transplantation

Regenerative medicine combines ideas from:

cell biology + genetics + medicine + engineering + materials science

---

Replacing Damaged Cells

Consider a disease that destroys one particular cell type.

A regenerative strategy might be:

stem cells

↓

directed differentiation

↓

desired specialized cells

↓

cells purified and checked

↓

cells transplanted

↓

damaged tissue function potentially improved

This sounds straightforward, but every stage presents scientific challenges.

---

Growing the Correct Cell

Scientists must first persuade stem cells to differentiate into the correct cell type.

Cells normally receive complex signals during development.

Researchers attempt to reproduce these signals using:

• growth factors
• signalling molecules
• nutrients
• physical environments
• carefully timed changes in culture conditions

If the wrong signals are provided, the cells may differentiate incorrectly.

---

Making Functional Cells

Producing cells that look like neurons or heart cells is not enough.

They must actually function correctly.

For example, replacement heart cells must:

• contract appropriately
• communicate with neighbouring cells
• respond to electrical signals
• integrate into heart tissue

Replacement neurons may need to:

• form appropriate connections
• release the correct neurotransmitters
• receive electrical signals
• survive for long periods

Regenerative medicine therefore requires functional integration, not merely cell production.

---

Tissue Engineering

Some regenerative medicine approaches combine cells with artificial structures called scaffolds.

A scaffold provides a three-dimensional framework on which cells can grow.

A simplified process is:

scaffold + cells + growth signals

↓

cells attach

↓

cells grow

↓

extracellular material develops

↓

tissue-like structure forms

Scientists are investigating tissue engineering for structures such as:

• skin
• cartilage
• bone
• blood vessels

Building complete, complex organs is much more difficult.

---

Why Is Growing an Organ Difficult?

An organ is not simply a large collection of identical cells.

Consider the heart.

It contains:

• cardiac muscle cells
• blood vessels
• connective tissue
• nerve cells
• valves
• several other cell types

These structures must be arranged correctly.

Cells also need:

• oxygen
• nutrients
• waste removal
• communication
• mechanical support

One major challenge is creating a functional blood-vessel network.

Without blood vessels, cells deep inside a large engineered tissue cannot receive enough oxygen.

---

Organoids

Stem cells can sometimes be grown into small three-dimensional structures called organoids.

Organoids reproduce some features of real organs.

Researchers have developed organoids modelling tissues such as:

• intestine
• brain
• kidney
• liver
• lung

Organoids are not usually complete miniature organs.

Instead, they can model selected aspects of tissue organization and function.

---

Why Are Organoids Useful?

Organoids can help scientists:

• study human development
• investigate diseases
• test drugs
• study infections
• examine genetic disorders
• investigate possible treatments

For example, researchers can create organoids from patient-derived iPSCs.

This allows them to study disease processes using cells with the patient's genetic background.

---

Disease Modelling

Imagine a patient has a genetic condition affecting neurons.

Scientists could potentially:

collect patient's skin cells

↓

produce iPSCs

↓

differentiate iPSCs into neurons

↓

study neurons in laboratory

↓

test possible treatments

This allows scientists to investigate disease without removing neurons directly from the patient's brain.

---

Drug Testing

Stem-cell-derived cells can also be useful for testing medicines.

Suppose researchers develop a new heart medicine.

They may test its effects on laboratory-grown human heart cells.

Scientists can investigate:

• effectiveness
• toxicity
• changes in contraction
• electrical activity
• cellular damage

This does not replace clinical trials, but it can provide useful information earlier in drug development.

---

Repairing the Heart

A heart attack can destroy cardiac muscle cells.

Adult human heart tissue has limited ability to replace large numbers of lost heart muscle cells.

Researchers are therefore investigating whether stem cells could produce replacement cardiac cells.

Potential challenges include:

• cell survival
• correct electrical integration
• abnormal heart rhythms
• immune rejection
• producing enough cells
• controlling differentiation

This remains an active area of research.

---

Repairing Nerve Tissue

The nervous system is another major target for regenerative medicine.

Researchers investigate stem-cell approaches for conditions involving loss or damage to neurons.

Potential areas of research include:

• spinal-cord injury
• Parkinson's disease
• retinal degeneration
• other neurological conditions

The challenge is not simply creating neurons.

New neurons must integrate correctly into extremely complex neural networks.

---

Producing Insulin-Secreting Cells

Stem-cell research is also being used to investigate replacement of pancreatic beta cells.

Recall:

beta cells → produce insulin

In Type 1 diabetes, these cells are destroyed by the immune system.

A potential regenerative strategy is:

pluripotent stem cell

↓

directed differentiation

↓

insulin-producing cells

↓

transplantation

However, the immune system that contributed to destruction of the original beta cells creates an additional challenge.

---

Immune Rejection

The immune system can recognize cells from another person as foreign.

This can cause rejection.

A patient's immune system may attack transplanted cells.

Possible strategies include:

• matching donors and recipients
• immune-suppressing medicines
• using the patient's own cells when possible
• engineering cells to alter immune recognition
• protective encapsulation technologies

Immune rejection remains an important challenge in transplantation and regenerative medicine.

---

Autologous and Allogeneic Cells

Two useful terms are:

Autologous

Cells come from the same person who will receive them.

Allogeneic

Cells come from another person.

Autologous cells can reduce some immune-matching problems.

However, producing individualized cells can be expensive and time-consuming.

Allogeneic cells may be easier to manufacture at scale but can create greater immune-compatibility challenges.

---

Stem Cells and Gene Therapy Together

Stem-cell technology and gene therapy can be combined.

Suppose a patient has a genetic disease affecting blood cells.

Scientists might:

remove blood-forming stem cells

↓

genetically correct or modify them

↓

check the modified cells

↓

return them to the patient

↓

modified stem cells produce healthier blood cells

This combines:

stem cells + genetic engineering + regenerative medicine

---

The Risk of Uncontrolled Cell Division

Stem cells can divide.

That ability is useful—but it can also create risk.

If cell division becomes uncontrolled:

cells continue dividing → abnormal growth → possible tumour

Pluripotent stem cells are especially powerful because they can divide and differentiate extensively.

Scientists must therefore ensure that transplanted cell populations do not contain inappropriate undifferentiated cells that could form abnormal growths.

---

Controlling Differentiation

Imagine researchers want to produce neurons.

They begin with one million pluripotent stem cells.

After differentiation:

• 920,000 become the desired neural cells
• 70,000 become other cell types
• 10,000 remain undifferentiated

Would it automatically be safe to transplant the entire population?

No.

Scientists would need to consider the unwanted and undifferentiated cells.

This illustrates why purity and quality control are essential in regenerative medicine.

---

Stem-Cell Treatments vs Unproven Treatments

Because stem cells sound promising, some clinics have marketed treatments that have not been adequately demonstrated to be safe or effective.

A scientific claim should therefore be evaluated using evidence.

Important questions include:

• Has the treatment been tested in controlled studies?
• Has it undergone appropriate clinical trials?
• What evidence supports the claimed benefit?
• What adverse effects have been observed?
• Is the treatment appropriately regulated?
• Are long-term outcomes known?

"Uses stem cells" does not automatically mean "proven to work."

---

Benefits of Stem-Cell Research

Stem-cell science can contribute to several areas.

Understanding Development

Researchers can study how cells become specialized.

Disease Modelling

Patient-derived cells can model diseases.

Drug Development

Specialized human cells can help test potential medicines.

Tissue Repair

Stem cells may provide replacement cells for damaged tissues.

Blood Disorders

Blood stem-cell transplantation is already an established treatment for several conditions.

Gene Therapy

Stem cells can be genetically modified before being returned to patients.

---

Limitations and Challenges

Stem-cell therapies also face significant difficulties.

These include:

• controlling differentiation
• producing pure populations
• immune rejection
• tumour formation
• getting cells to the correct location
• integrating cells into existing tissue
• producing blood vessels
• long-term survival
• manufacturing at large scale
• high cost

The biological challenge is not simply:

"Can we grow cells?"

It is:

Can we produce the correct cells, in sufficient numbers, safely integrate them into the body, and make them function for an appropriate length of time?

---

Ethical Issues: Embryonic Stem Cells

Embryonic stem-cell research has generated significant ethical debate because obtaining certain embryonic stem-cell lines involves the use and destruction of early-stage human embryos.

Different people and societies hold different views about the moral status of embryos.

The debate can involve questions such as:

• What moral status should an early embryo have?
• Under what circumstances may embryos be used in research?
• Was informed consent obtained from donors?
• Could another stem-cell source be used?
• What medical benefits might result?
• How should research be regulated?

Science can provide evidence about embryos and stem cells, but ethical decisions also involve values.

---

Sources of Embryos

Some embryonic stem-cell research has involved embryos remaining from in vitro fertilization (IVF) procedures that would otherwise not be used for pregnancy.

This raises questions involving:

• donor consent
• storage
• ownership
• research use
• destruction of embryos

Regulations differ between countries.

Researchers must follow the laws and ethical-review procedures that apply where the work is conducted.

---

Adult Stem Cells and Ethics

Adult stem cells generally raise fewer concerns about embryo use because they can be obtained from tissues such as:

• bone marrow
• blood
• skin-associated tissues

However, ethical questions still exist.

These can involve:

• informed consent
• risks to donors
• ownership of biological samples
• privacy
• commercialization
• fair access to treatments

Ethical evaluation is therefore relevant to all biomedical research, not only embryonic stem cells.

---

iPSCs and Ethical Questions

Induced pluripotent stem cells avoid some of the ethical issues associated with obtaining embryonic stem cells because they can be created from mature body cells.

However, iPSCs do not eliminate every ethical concern.

Questions can still involve:

• genetic privacy
• consent
• ownership of cell lines
• commercialization
• creation of reproductive cells
• genetic modification
• future research uses

A new technology may solve one ethical problem while creating different questions.

---

Donor Consent

People donating biological material should understand how their cells may be used.

This is part of informed consent.

Important questions include:

• What research will be performed?
• Will cells be stored?
• Could cells be genetically modified?
• Could cell lines be shared with other researchers?
• Could commercial products result?
• How will genetic information be protected?

Because cell lines may survive in laboratories for many years, these questions can have long-term importance.

---

Access and Fairness

Regenerative therapies can be technically complex and expensive.

If an effective treatment costs a very large amount:

• Who can access it?
• Should insurance systems pay?
• Should governments subsidize it?
• How should limited treatments be allocated?
• Will wealthy countries gain access first?

These questions are part of healthcare equity.

A therapy's impact depends not only on whether it works, but also on whether people can realistically access it.

---

Evaluating Stem-Cell Research

A strong evaluation should consider both scientific and ethical evidence.

Scientific Questions

• Does the treatment work?
• Are the cells correctly differentiated?
• Can they integrate into tissue?
• What are the risks?
• How long does the benefit last?

Ethical Questions

• Where did the cells come from?
• Was informed consent obtained?
• Are embryos involved?
• Are donors protected?
• Who benefits from the research?
• Is access fair?

Practical Questions

• How expensive is treatment?
• Can it be manufactured reliably?
• Can it be scaled?
• Are alternatives available?

Good evaluation considers benefits, risks, evidence, ethics, and practical limitations together.

---

Worked Example 1: Potency

A stem cell can produce:

• red blood cells
• white blood cells
• platelet-producing cells

but cannot normally produce neurons or heart muscle cells.

Would this cell be more appropriately described as pluripotent or multipotent?

Answer

Multipotent.

It can produce several related blood-cell types but does not normally produce cells from essentially all body tissues.

---

Worked Example 2: Differentiation

A stem cell and a neuron contain essentially the same genome.

Why do they behave differently?

Answer

They have different patterns of gene expression.

Different genes are active at different levels.

This causes the cells to produce different proteins, giving them different:

• structures
• properties
• functions

---

Worked Example 3: Regenerative Medicine

A patient has damaged cartilage.

Scientists grow cartilage-producing cells from stem cells and implant them into the damaged area.

Why is this an example of regenerative medicine?

Answer

The goal is to restore damaged tissue using replacement cells.

Rather than simply reducing symptoms, the treatment attempts to repair or replace the damaged biological structure.

---

Worked Example 4: Evaluating a Claim

A clinic advertises:

"Our stem cells can cure arthritis, spinal-cord injury, diabetes, Alzheimer's disease, and heart disease."

What questions should you ask?

Answer

Important questions include:

• What type of stem cells are used?
• What clinical-trial evidence exists?
• How many patients were studied?
• Was there a control group?
• What outcomes were measured?
• What adverse effects occurred?
• How long were patients followed?
• Has the treatment been independently evaluated?
• Is it appropriately regulated?

A broad medical claim requires strong evidence.

---

Worked Example 5: Ethical Decision

Two research teams want to study a neurological disease.

Team A proposes using an established embryonic stem-cell line.

Team B proposes producing iPSCs from adult skin cells.

Does the existence of iPSCs automatically make Team A's research unethical?

Answer

Not automatically.

An ethical evaluation would consider:

• the scientific question
• whether the cell types are equivalent for that research
• source and history of the embryonic cell line
• donor consent
• regulations
• potential benefits
• available alternatives

Ethical evaluation requires more than simply identifying which type of stem cell is being used.

---

Common Mistakes

Mistake 1: "Stem cells can become any cell."

Not all stem cells have the same developmental potential.

Some are pluripotent, while others are multipotent or more restricted.

---

Mistake 2: "All stem cells come from embryos."

Stem cells can also be found in adult tissues, and iPSCs can be produced by reprogramming specialized cells.

---

Mistake 3: "Differentiation changes the DNA sequence into a different genome."

Most differentiation primarily involves changes in gene expression, not replacement of the entire genome.

---

Mistake 4: "Adult stem cells are pluripotent."

Most adult stem cells have more restricted developmental potential.

Many are multipotent.

---

Mistake 5: "iPSCs are collected from embryos."

iPSCs are produced by reprogramming differentiated cells.

---

Mistake 6: "If we can grow a cell in the laboratory, we can automatically use it to repair an organ."

Replacement cells must survive, function, integrate correctly, and avoid causing harm.

---

Mistake 7: "Stem-cell medicine is entirely experimental."

Blood-forming stem-cell transplantation is an established medical treatment.

Other applications remain experimental.

---

Mistake 8: "Every treatment advertised as stem-cell therapy has been scientifically proven."

Some marketed treatments lack adequate evidence for safety or effectiveness.

---

Mistake 9: "Regenerative medicine only uses stem cells."

Regenerative medicine can also involve:

• biomaterials
• tissue engineering
• gene therapy
• growth factors
• engineered tissues

---

Mistake 10: "The ethical debate is simply science versus religion."

Ethical questions are much broader and can involve:

• embryo status
• consent
• safety
• donor rights
• commercialization
• privacy
• fairness
• access

People may reach different conclusions based on different ethical frameworks.

---

Check Your Understanding

1. Stem Cells

State the two major characteristics of a stem cell.

2. Differentiation

Explain how a stem cell can become a specialized cell even though both cells contain essentially the same DNA.

Use:

• gene expression
• proteins
• specialization

in your answer.

3. Potency

Arrange these from greatest to most restricted developmental potential:

multipotent – totipotent – pluripotent

4. Compare

Compare:

• embryonic stem cells
• adult stem cells
• induced pluripotent stem cells

Consider their origin and developmental potential.

5. Medical Application

Explain how hematopoietic stem cells can be used to treat some blood diseases.

6. Regenerative Medicine

Define regenerative medicine and give two possible applications.

7. iPSCs

Explain how iPSCs are produced and identify two reasons they are useful in research.

8. Challenges

Identify four scientific challenges that must be solved before stem-cell-derived cells can be safely transplanted.

9. Ethics

Explain why embryonic stem-cell research generates ethical debate.

Identify at least two different considerations.

10. Challenge

Scientists develop a method for producing heart muscle cells from a patient's own iPSCs.

The cells contract normally in the laboratory.

Does this prove they are ready to treat heart-attack patients?

Explain what additional questions scientists would need to investigate.

Consider:

• cell purity
• survival
• electrical integration
• blood supply
• tumour risk
• long-term function
• manufacturing
• clinical evidence

---

Key Terms

• Stem cell – relatively unspecialized cell capable of self-renewal and differentiation
• Self-renewal – ability to divide while maintaining a stem-cell population
• Differentiation – process through which cells become specialized
• Specialized cell – cell adapted to perform particular functions
• Gene expression – use of genetic information to produce functional products
• Potency – range of cell types a stem cell can potentially produce
• Totipotent – capable of producing embryonic and supporting extraembryonic cell types required during very early development
• Pluripotent – capable of producing essentially all major body cell types
• Multipotent – capable of producing several related cell types
• Embryonic stem cell (ESC) – pluripotent stem cell derived from an early-stage embryo
• Adult stem cell – stem cell found in developed tissues
• Hematopoietic stem cell – stem cell capable of producing blood-cell lineages
• Induced pluripotent stem cell (iPSC) – differentiated cell reprogrammed into a pluripotent-like state
• Regenerative medicine – field aimed at repairing, replacing, or regenerating damaged tissues
• Tissue engineering – use of cells, materials, and engineering approaches to create or repair tissues
• Scaffold – structure supporting cell attachment and tissue development
• Organoid – three-dimensional cell culture reproducing some characteristics of an organ
• Autologous – originating from the same person receiving the cells
• Allogeneic – originating from another individual
• Immune rejection – immune attack against transplanted cells or tissue
• Informed consent – agreement based on understanding relevant information, risks, and uses
• Stem-cell transplant – transfer of stem cells to replace or rebuild a cell-producing system

---

Key Takeaways

• Stem cells have two defining properties: self-renewal and differentiation.
• Differentiation allows stem cells to produce specialized cells such as blood cells, neurons, and muscle cells.
• Cell specialization occurs largely because different cells express different combinations of genes, even though they contain essentially the same genome.
• Stem cells differ in potency: totipotent, pluripotent, multipotent, and more restricted cells have different developmental possibilities.
• Embryonic stem cells are pluripotent and can produce a very wide range of specialized cell types.
• Adult stem cells maintain and repair tissues and generally have more restricted developmental potential.
• Induced pluripotent stem cells (iPSCs) are differentiated cells reprogrammed into a pluripotent-like state.
• Blood-forming stem-cell transplantation is an established medical treatment for some blood and immune-system diseases.
• Regenerative medicine aims to repair, replace, or regenerate damaged cells and tissues.
• Tissue engineering can combine stem cells with scaffolds and biomaterials.
• Organoids allow researchers to model aspects of human tissues and diseases in the laboratory.
• Patient-derived iPSCs can be used for disease modelling and drug testing.
• Potential regenerative applications include repairing heart, nerve, retinal, pancreatic, bone, and cartilage tissues.
• Major challenges include controlling differentiation, immune rejection, tumour formation, tissue integration, blood supply, manufacturing, and long-term function.
• Stem-cell and gene-therapy technologies can be combined by genetically modifying stem cells before returning them to a patient.
• Embryonic stem-cell research raises ethical questions involving the source and moral status of embryos, consent, and research regulation.
• Adult stem cells and iPSCs avoid some embryo-related concerns but still raise questions involving consent, privacy, ownership, safety, and access.
• A treatment being described as a "stem-cell therapy" does not by itself demonstrate that it is safe or effective.
• Stem-cell research combines developmental biology, genetics, medicine, and engineering and has become a major part of modern regenerative medicine.